EtiraRX, Inc. funding
EtiraRX, Inc., a biotechnology company based in Dallas, TX, filed a Form D with the SEC on May 14, 2026 and reported $2.3M raised of a $3M offering.
Amount raised$2.3M
Offering size$3M
Filed with the SECMay 14, 2026
First saleApril 17, 2026
IndustryBiotechnology
SecuritiesEquity
LocationDallas, TX
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far21
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 14
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care